Company profile for Confo Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Confo Therapeutics is a drug discovery company building a unique pipeline of GPCR targeted therapeutics addressing unmet medical need. The company was founded in 2015 as a spin-off from the Vrije Universiteit Brussel and VIB and capitalizes on the CONFO® body technology developed by Prof. Jan Steyaert at VIB Structural Biology Research Center, Vrije Universiteit Brussel.Confobodies are camel single domain antibodies that stab...
Confo Therapeutics is a drug discovery company building a unique pipeline of GPCR targeted therapeutics addressing unmet medical need. The company was founded in 2015 as a spin-off from the Vrije Universiteit Brussel and VIB and capitalizes on the CONFO® body technology developed by Prof. Jan Steyaert at VIB Structural Biology Research Center, Vrije Universiteit Brussel.Confobodies are camel single domain antibodies that stabilize distinct druggable conformers of flexible protein targets and reveal previously inaccessible structural features.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Pleinlaan 2 Building E, 7th Floor, Room E7.6 1050 Brussels
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/08/3163128/0/en/Confo-Therapeutics-Awarded-VLAIO-Grant-for-Development-of-Ultra-Long-Acting-Antibody-Based-GPCR-Therapeutics-in-Endocrine-and-Metabolic-Conditions.html

GLOBENEWSWIRE
08 Oct 2025

https://www.businesswire.com/news/home/20241001610010/en

BUSINESSWIRE
01 Oct 2024

https://www.businesswire.com/news/home/20240725025121/en

BUSINESSWIRE
25 Jul 2024

https://www.businesswire.com/news/home/20240328537717/en

BUSINESSWIRE
28 Mar 2024

https://www.businesswire.com/news/home/20230912857351/en

BUSINESSWIRE
12 Sep 2023

https://www.businesswire.com/news/home/20230829239160/en

BUSINESSWIRE
29 Aug 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty